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Persistent impairment based symptoms post Mild Traumatic Brain Injury: does a 
standard symptom scale detect them? 
ABSTRACT 
Aim To further explore symptoms in patients beyond the expected recovery period post mild 
Traumatic Brain Injury (mTBI) that are potentially indicative of impairment.  
Methods Ninety-four individuals (62 diagnosed with mTBI within the previous 4-24 weeks 
and 32 healthy controls) participated in the study. Participants in the mTBI group were 
further grouped as symptomatic (n=33) or asymptomatic (n=29) based on their spontaneous 
report of symptoms at the time of screening. Measures included a demographic 
questionnaire, 8 impairment specific self-report clinical tools, and a standard post-mTBI self-
report symptom scale (Head Injury Scale (HIS)).  
Results Compared to the control group, scores for all instruments (including the HIS) were 
higher in the symptomatic mTBI group (P< .05), and higher for the neck disability and 
hyperarousal measures in the asymptomatic mTBI group (p<0.035), but not the HIS 
(p>0.093). Overall 94% of the symptomatic and 62% of the asymptomatic participants post-
mTBI, recorded scores considered to be clinically relevant on at least one impairment 
screening tool. In contrast, only 28% of the asymptomatic mTBI group recorded a clinically 
relevant score for the HIS.  
Conclusion Symptoms indicative of persisting impairments beyond the expected recovery 
period were apparent in a substantial proportion of individuals post mTBI. Furthermore, a 
high percentage of individuals initially reporting as symptom free demonstrated clinically 
relevant scores on at least one impairment screening tool. Findings also suggest that a 
standard post-mTBI self-report symptom scale may often not detect the presence of 
persisting symptoms.  
Key words concussion, impairment, “Mild traumatic brain injury”, “self-report symptom”, tool 
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INTRODUCTION 
Self-reported symptom resolution following a Mild Traumatic Brain Injury (mTBI) is thought to 
occur within the first 10 to 14 days post-injury in adults (1-5). As such self-reported symptom 
resolution is viewed as an initial indicator of recovery (1-5) and is often used as a guideline 
when returning individuals to pre-injury activity (including contact sports) (1, 2, 4, 5). 
Persistence of symptoms beyond 1-3 months is also a primary clinical indicator for diagnosis 
of post-concussion syndrome (2, 6, 7). However, recent evidence suggests that the use of 
symptom behaviour post-mTBI to guide such decisions is not straightforward.   
Studies have demonstrated persistent multi-system impairments, particularly sensorimotor 
and physiological disturbances, following mTBI, beyond expected recovery times (8-17) and 
following self-reported symptom abatement (8, 11, 13, 14). One recent review (18) identified 
persistent impairments in 36 individual sensorimotor and/or physiological variables (postural 
control, oculomotor function, and sleep) in individuals subacutely post mTBI, with additional 
meta-analysis evidence of impaired heart-beat regulation. However only 9/13 studies in this 
review investigated concurrent symptoms, which were reported as absent in 5 studies, while 
the remaining 4 identified symptoms using impairment specific self-report clinical tools 
related to psychological distress and sleep quality, not standard post mTBI self-report 
symptom scales (18). Such findings suggest potentially greater diversity and persistence of 
impairments following mTBI than originally thought, which may not be detected with 
commonly used instruments.    
Currently only a few validated self-reported symptom tools are used in practice post mTBI 
(19-21). The Head Injury Scale (HIS) is one tool and contains 9 items measuring frequency 
and severity of symptoms relating to somatic, neurobehavioral and cognitive domains (20, 
22). Based on the recent studies indicating the diverse nature of impairments potentially 
presenting post-mTBI (8-16, 18, 23),   it is unknown if the limited items contained within 
single instruments such as the HIS are sufficient to screen this patient population. Potentially 
a battery of validated impairment specific self-report clinical tools may be more appropriate. 
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Evolving evidence suggests that clinical instruments relating to neck pain and disability (24, 
25), fatigue (26), sleep quality (27)  and psychological distress (28) may also be relevant in 
patients post-mTBI. (Figure1) Such instruments may give insight regarding persisting 
sensorimotor, musculoskeletal, endocrine, neurodegenerative, or affective deficits in these 
patients (15, 29-32).  
Figure 1. Impairment Specific Self-Reported Clinical Tools according to Cervical, 
Sensorimotor, Physiological and Psychological Domains (insert here) 
The aim of this study was therefore to further investigate whether symptoms potentially 
indicative of impairment persist in patients beyond the expected recovery period post-mTBI, 
and whether a standard self-report symptom tool (ie. HIS) would also identify persistent 
symptoms. Specifically scores from several validated impairment specific self-report clinical 
tools (referred to as impairment specific tools) (Figure 1) were compared in individuals post-
mTBI and healthy controls.  We hypothesised that scores from these impairment specific 
tools would be elevated (to a clinically relevant level) in a substantial proportion of individuals 
post-mTBI (Hypothesis 1) compared to healthy controls. We further hypothesised that these 
elevated scores would also be evident in some individuals who at the time of assessment 
spontaneously reported themselves to have complete symptom resolution (Hypothesis 2). 
Another aim of the study was to compare findings from the impairment specific tools to the 
HIS.  It was hypothesised that the impairment specific tools would identify potentially 
relevant symptoms in a greater proportion of individuals post-mTBI than the HIS (Hypothesis 
3).     
MATERIALS AND METHODS 
Participants 
Participants included 62 individuals diagnosed with mTBI and 32 healthy controls aged 
between 18-60 years who had never sustained a mTBI. Participants were recruited via the 
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institutions greater community, social media advertising, and the Emergency Department 
(ED) of a nearby teaching tertiary hospital. Data collection for this study took place between 
October 2016 and July 2018. 
Participants in the mTBI group were included if they had received a diagnosis of mTBI or 
concussion from a medical specialist. Specifically, this had to be based on currently 
recommended diagnostic criteria for mTBI including: Glasgow Coma Scale score of 13-15, 
Post Traumatic Amnesia < 24 hours, and loss of consciousness < 30 minutes following injury 
(2, 33, 34). In the absence of any of these specific criteria,  persistent symptoms evident of 
head injury, such as confusion and disorientation, mental fog, headache, nausea or 
dizziness, for at least 30 minutes post-injury had to be present (33) in addition to formal 
diagnosis of mTBI. 
Exclusion Criteria for both groups included: 
• intra-cranial bleed on computed tomography or magnetic resonance images  
• past history of a diagnosed neurological condition (including but not limited to 
seizures, epilepsy, diagnosed brain tumours or behavioural conditions)  
• autonomic nervous system disorders (including cardiac dysrhythmias and sleep 
disorders)  
• persistent or prior idiopathic or trauma induced neck pain  
• vestibular disorders  
• concurrent acute orthopaedic conditions  
• psychotropic medications use 
•  history of substance abuse  
All participants provided written informed consent before participating. The study received 
ethical approval from the University of XXXXXX and XXXXXX XXXX Human Research 
Ethics Committees (Bellberry HREC 2016-04-311 and HREC/17/QPAH/30).  
Measures 
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Measures including demographic information and three levels of self-report symptom 
measures were completed by all participants in the mTBI group 4 weeks to 6 months post-
injury, and at a time of convenience for the healthy control group using an online tool 
(Checkbox Survey Inc.).  
Demographic Measures 
Demographic measures were utilised for descriptive purposes and to pre-evaluate group 
comparability.  All participants reported age, gender, and activity level (measured by the 
International Physical Activity Questionnaire short form (35)). Participants in the mTBI group 
also reported mechanism of their current mTBI, as well as total number of diagnosed mTBI’s 
(including current).  
Spontaneous Self-Reported Symptoms Measure 
A spontaneous self-reported symptom measure was taken at the time of assessment for 
participants in the mTBI group prior to the other self-reported symptom measures for the 
purposes of subgrouping to either the symptomatic or asymptomatic mTBI groups. Grouping 
was based on individual responses (yes/no) to the question “Are you continuing to 
experience symptoms in relation to your most recent concussion?” The term concussion was 
used instead of “mild traumatic brain injury” since it is more widely utilised and understood 
with respect to the clinical manifestations of mTBI.  
Standard Self-Reported Symptoms Measure 
The Head Impact Scale (9- items) (20) was included as a standard post-concussion self-
reported symptom measure. This tool lists commonly reported post-concussion symptoms 
and contains separate subscales for frequency (hours per day) and severity. Scores range 
from 0 to 6 with increasing frequency or severity indicated by higher scores then summed to 
provide a cumulative score for each scale.  The HIS was selected based on its higher 
psychometric properties when compared to other available tools (19). In the absence of a 
published threshold, we used the averaged score of the frequency (3.87/54) and severity 
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(4.96/54) subscales previously reported in healthy individuals (22) as a clinically relevant 
score (>4) for the HIS.  
Impairment Specific Self-report Clinical Tools 
The following impairment specific tools were used to quantify impairments within specific 
system domains (Figure 1) previously identified to potentially demonstrate impairment post 
mTBI (eg. sensorimotor, musculoskeletal, physiological, psychological) based on their 
established validity (24, 26-28, 36-41).   
The Neck Disability Index: comprised of 10 items examining neck pain related functional 
limitations (24). Each item has 6 separate responses related to an activity. Scores are 
assigned between 0 and 5 and an overall possible score of 50, expressed as a percentage. 
A score of >10% indicates significant impairment and was used as the clinically relevant 
threshold in this study (24). 
The Dizziness Handicap Inventory short form (DHI-13): a shortened version (36) of the 
original 25 item checklist(42), explores the effects of eye and head, or full body motion as 
well as mood on dizziness related impairment. Recommended conversion of the final score 
(out of 13) to a value out of 100 is performed (36), so that higher values represent increasing 
handicap and the threshold of 16/100 for mild impairment can be applied as clinically 
relevant (42). 
Visual Complaint Index: consists of 16 visual symptoms with options to rate frequency and 
severity on 3 and 4 point rating scales respectively (37). Scores for each item are then 
multiplied and added overall to achieve a score out of 164. A mean score of 27.4 previously 
identified in individuals with neck pain (37) was used to identify clinically relevant vision 
related complaints. 
Space and Motion Discomfort II (SMD II): a  9-item index of space and motion discomfort 
(38) aids in identify individuals with situational vertigo due to vestibular impairment. Scores 
for each item (0-3 rating scale) are multiplied by a factor of 10 and summed for cumulative 
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score. A mean total score of 82.4/270 previously recorded in a vestibular population (38) 
was the nominated clinically relevant threshold. 
The Hyperarousal Subscale:  a measure of arousal, forms one of three subscales in the 
symptom component of the Posttraumatic Diagnostic Scale (40). Each of the five subscale 
items are scored with respect to frequency using a 4-point scale (43) and summed. A value 
of 6/15, predictive of poor long-term outcome following whiplash (39) was selected as the 
clinically relevant threshold. While this is traditionally used as a psychological measure of 
stress related to injury, it could potentially be indicative of ANS dysfunction post mTBI (44).  
Fatigue Severity Scale (FSS): a 9-item questionnaire for measurement of disabling fatigue 
over the previous week requires responders to rate agreement with various statements on a 
7-point Likert scale. Item scores are summed, then divided by nine for a final score out of 7. 
Scores of  >4.7 was selected as the clinically relevant threshold since this has previously 
been reported in patient groups with known susceptibility to fatigue (26). 
Pittsburgh Sleep Quality Index (PSQI): a measure of sleep quality over the previous month 
(27), consists of 19 items scored individually and further grouped into 7 equally weighted 
component scores. The global score/21 is the summed result of all component scores. A 
score of >5 has been found to exhibit 84.4% specificity when used to identify clinically 
relevant poor sleep (27).   
Depression, Anxiety and Stress Scale short form (DASS-21):  a 21 item abbreviated form of 
the 45 item DASS (28) consists of three individual subscales scored independently to 
measure dimensions of depression and anxiety as well as physical arousal (41). Each item 
is scored on a 4-point scale and symptom cluster scores for depression, anxiety or stress 
are summed to give an overall value for each disorder. Minimal clinically relevant scores are 
9, 7 and 14 for depression, anxiety and stress respectively (45, 46).  
Statistics 
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All data were analysed using the statistic software SPSS (IBM Corp. Released 2016. IBM 
SPSS Statistics for Windows, Version 24.0. Armonk, NY: IBM Corp.). Data were grouped via 
the spontaneous self-reported symptom measure response into symptomatic mTBI, 
asymptomatic mTBI, and healthy control (HC) groups.  
Group Comparisons (Hypotheses 1 and 2) - Group data were analysed for descriptive and 
comparative purposes. Group comparisons were undertaken by exploring central tendency 
of the recorded scores as well as dichotomising individual scores based on clinically relevant 
thresholds.  
A Shapiro-Wilk test investigated distribution of data overall and by group. One-way between-
groups ANOVA identified demographic differences between groups where data was 
normally distributed. Non-normally distributed data was analysed using the Kruskal-Wallis 
test with Bonferroni correction for type-1 error (a priori sig. value p<0.05). Post-hoc analysis 
using Spearman’s Rho Correlation identified any relationships between; 1/ IPAQ scores and 
self-reported symptoms, and 2/ total number of concussions and attainment of one or more 
impairment specific tools reaching clinically relevant thresholds. 
Individual scores for both the HIS and the 8 individual impairment specific tools were 
dichotomised as either clinically relevant (=1) or not clinically relevant (=0).  For each 
participant, overall evidence of clinical impairment (i.e. at least one score was clinically 
relevant) was also rated as present (=1) or absent (=0). Fishers Exact Test was used to 
identify significant proportional differences between groups of individuals scoring clinically 
relevant thresholds on one or more impairment specific tool, or the HIS.  
Comparison of Standard and Impairment Specific Tools (Hypothesis 3) – Individual cases 
where scores were clinically relevant for one or more of the impairment specific tools but not 
for the HIS (and vice versa) were identified. The PSQI measure was not included in this 
analysis as the proportion of individuals exceeding clinically relevant scores was high in all 
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groups with no proportional difference between healthy controls and asymptomatic mTBI 
participants (p=0.437). 
RESULTS 
Overall 94 (32 Healthy controls, 29 asymptomatic and 33 symptomatic) participants were 
included in the current study.  Mechanisms of injury for individuals post mTBI included falls 
(n=17), motor vehicle accidents (n=8), sport-related mTBI (n=28) and being struck in the 
head by an object (n=9).  
Group Comparisons - There were no age or gender group differences. Despite the 
symptomatic mTBI group recording significantly less activity levels (IPAQ) than healthy 
controls (p=0.03) (Table 1), IPAQ scores were not significant correlated with any of the 
screening tool scores (including the HIS subscales) (Spearman’s Rho ρ < ± .16, p >0.12). 
Furthermore the number of prior concussions was not associated with at least one 
impairment specific tool reaching the clinical threshold (p = 0.07). 
Table 1: Characteristics of the Healthy Control (HC), Asymptomatic (Asymp) and 
Symptomatic (Symp) mild Traumatic Brain Injury (mTBI) groups. 
 
Group ANOVA 
 HC 
(N=32) 
Asymp mTBI 
(N=29) 
Symp mTBI 
(N=33) 
p-value 
(HC*Asymp) 
p-value 
(HC*Symp) 
p-value 
(Asymp*Symp) 
Gender  
(% F) 59% 45% 51% 0.50 0.81 0.86 
Age (years) 29.8 (8.9) 30.03 (11.7) 33.70 (14.3) 0.99 0.38 0.45 
IPAQ (METs) 3177.4 (1827.8) 
5193.2 
(4335.8) 
5862.8 
(936.6) 0.14 0.03* 0.80 
Days Since 
Injury NA 80.74 (31.7) 75.67 (41.1) NA NA 0.79 
No. mTBI 0 1.57 (1.2) 1.45 (0.8) NA NA 0.84 
Values presented as mean (± SD). Abbreviations: N= Number, F= females, IPAQ= International 
Physical Activity Questionnaire, METs = Metabolic Equivalent of Task,  No. mTBI= Number of 
diagnosed (including current) mTBI, NA = Not applicable *Sig p <0.05 
The symptomatic mTBI group demonstrated significantly elevated scores for all impairment 
specific tools and HIS subscales compared to healthy controls (p ≤ 0.01, Table 2) and the 
asymptomatic mTBI group (p<0.05, with the exception of the DASS-A measure). The 
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asymptomatic mTBI group also reported significantly higher levels of neck pain and disability 
(p=0.03) and hyperarousal when compared to healthy controls (p=0.00) (Table 2). 
Table 2: Comparative data for all of the impairment specific tools and Head Injury 
Scale (both subscales) for the Healthy Control (HC), Asymptomatic (Asymp) and 
Symptomatic (Symp) mild Traumatic Brain Injury (mTBI) groups.  
 
Group Kruskal-Wallis (adjusted for multiple tests) 
 
Questionnaire 
HC 
(N=32) 
Asymp 
mTBI 
(N=29) 
Symp  
mTBI 
N=33) 
p-value 
(HC*AS) 
p-value 
(HC*SY) 
p-value 
(AS*SY) 
Head Injury Scale- F 
(/54) 0 (0-2.25) 3 (0-6) 14 (9-24) 0.09 0.00* 0.00* 
Head Injury Scale- S 
(/54) 0  (0-2.25) 3 (0-6) 12 (8-22) 0.10 0.00* 0.00* 
Neck Disability Index 
(%) 0 (0-2) 4 (0-6) 16 (10-24) 0.03* 0.00* 0.00* 
Dizziness handicap 
inventory † (/100) 
100  
(100-100) 
100  
(89-100) 
62  
(51-89) 0.68 0.00* 0.00* 
SMDII (/27) 0 (0-0) 0 (0-1.11) 5.56 
 (3.33-10) 0.27 0.00* 0.00* 
Fatigue Severity Scale 
(/7) 
1.61  
(0.97 -2.69) 
3.11 
 (1.67-
3.89) 
4.44  
 (3.67-5.33) 0.06 0.00* 0.00* 
Hyper arousal 
Subscale PDS (/15) 0 (0-0) 2 (1-4) 6 (4-9) 0.00* 0.00* 0.00* 
Visual complaints 
index  (/164) 0 (0-2.25) 4 (0-7) 20 (5-34) 0.14 0.00* 0.00* 
Pittsburgh Sleep 
Quality Index (/21) 4 (3-6) 5 (3-8) 7 (5-9) 0.69 0.00* 0.04* 
DASS21_Depression 
(/42) 0 (0-2) 2 (0-8) 8 (2-16) 0.40 0.00* 0.02* 
DASS21_Anxiety (/42) 1 (0-4) 4 (0-4) 4 (2-10) 0.41 0.00* 0.29 
DASS21_Stress (/42) 2 (0-6.5) 4 (2-8) 12 (8-18) 0.67 0.00* 0.00* 
Values presented as median (Q1-Q3). Abbreviations: HC = Healthy Control AS = asymptomatic 
group, S = symptomatic  group, N = number, F = frequency, S = severity, SMD II = Space and Motion 
Discomfort II, PSD = Posttraumatic Diagnostic Scale,  DASS21 = Depression Anxiety and Stress 
Subscale short form (21 questions) and the respective subscale of this scale, *Sig p<0.05 
Thirty one (94%), 18(62%), and 4 (13%) individuals in the symptomatic mTBI, asymptomatic 
mTBI, and healthy control groups respectively, returned scores above the clinically relevant 
thresholds for one or more of the impairment specific tools.  Thirty-two (97%), 10 (34%) and 
4 (13%) individuals in the symptomatic mTBI, asymptomatic mTBI, and healthy control 
groups, respectively, displayed clinically relevant scores for the HIS (Table 3).  
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Table 3: Number of cases recording clinically relevant scores for the Head Injury 
Scale (HIS) and the Impairment Specific Tools for each group. 
Impairment Specific Tool 
Individuals exceeding cut off scores  
HC 
(N=32) 
Asymp 
mTBI 
(N=29) 
Symp  
mTBI 
(N=33) 
Neck Disability Index  (>10/100) 0 6 25 
Dizziness Handicap Inventory (>16/100) 1 5 23 
Space and Motion Discomfort II (>8.2/27) 0 0 14 
Visual Complaints Index (>28/168) 0 0 13 
Hyperarrousal subscale PDS  (>6/15) 0 1 19 
Fatigue Severity Scale (>4.7/7) 1 4 14 
Pittsburgh Sleep Quality Index (>5/21) 10 12 23 
DASS_Depression Subscale (>9/54) 3 7 15 
DASS_Anxiety Subscale (>7/54) 0 4 14 
DASS_Stress Subscale (>14/54) 1 4 13 
Head Injury Scale > 4 4 10 32 
At least 1 Impairment Specific Tool exceeded 
clinically relevant scores (not incl. PSQI) 4 18 31 
Abbreviations: HC = Healthy control group; Asymp mTBI = asymptomatic mTBI group; Symp mTBI = 
symptomatic mTBI group; PDS= Posttraumatic Diagnostic Scale, DASS = Depression, Anxiety, Stress 
Scale; No. = number of individual participants; HIS = Head Impact Scale scores above average of 
4/54;  
The Fishers Exact Test showed that both symptomatic and asymptomatic mTBI groups 
recorded clinically relevant scores on at least one of the impairment specific tools more 
frequently than controls, regardless of PSQI results (P<0.01). Additionally the symptomatic 
group recorded clinically relevant scores more frequently than the asymptomatic group 
(p<0.05) (Table 4). 
Table 4: Proportional group differences of clinically relevant scores for one or more 
impairment specific tools or for the HIS.  
 Group  Exact Sig. (2-Sided) 
 
HC 
(N=32) 
Asymp 
mTBI 
(N=29) 
Symp 
mTBI 
(N=33) 
p-value 
(HC*AS) 
p-value 
(HC*SY) 
p-value 
(AS*SY) 
>1 Impairment specific tool 
exceeded clinical thresholds 
(PSQI excluded) 
4 18 31 0.00* 0.00* 0.00* 
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>1 Impairment specific tool 
exceeded clinical thresholds 
(PSQI included) 
11 22 31 0.01* 0.00* 0.03* 
HIS >4 4 10 32 0.07 0.00 0.00 
 Abbreviations: Sig. =Significance, HC = Healthy Control group, Asymp mTBI/AS = asymptomatic 
mTBI group, Symp mTBI/SY = symptomatic mTBI group, N = number, PSQI = Pittsburgh Sleep 
Quality Index, *Sig p<0.05 
Comparison of Standard and Impairment Specific Tools – The 31 individuals in the 
symptomatic mTBI group who recorded clinically relevant scores for at least one impairment 
specific tool also scored above clinical threshold for the HIS. Of the 18 individuals in the 
asymptomatic group scoring above threshold on at least one impairment specific tool, only 8 
scored above threshold on the HIS. One individual in the symptomatic group, two in the 
asymptomatic group and two in the healthy control group recorded clinically relevant scores 
for the HIS but not for any impairment specific tool.  
DISCUSSION 
Findings support our first study hypothesis of significantly elevated impairment specific 
symptom scores in those in the subacute phase (both symptomatic and asymptomatic) post-
mTBI compared to healthy controls. In particular a substantial proportion of individuals (79% 
overall) in the mTBI group reported clinically relevant scores on one or more of the 
impairment specific tools compared to healthy controls (12.5% overall). This large proportion 
of mTBI cases recording clinically relevant symptom scores attests to the potentially diverse 
range of persisting impairments in this patient population.  
Elevated symptom levels for all sensorimotor and physiological impairment specific tools (as 
well as the HIS subscales) were identified in the symptomatic mTBI group compared to the 
asymptomatic mTBI and healthy control groups (p<0.00). Ninety-four percent (31/33) of 
symptomatic individuals recorded clinically relevant scores on the impairment specific tools 
indicative of potential underlying impairments. In support of our second hypothesis, 18 (62%) 
asymptomatic mTBI participants also recorded clinically relevant scores on at least one 
impairment specific tool. Overall higher levels of neck disability and hyperarousal were 
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observed in the asymptomatic mTBI group compared to the healthy control group (p<0.05). 
These results indicate that individuals may not recognise the persistence of symptoms post-
mTBI. Collectively the findings from the symptomatic and asymptomatic mTBI groups align 
with previous research reporting persistent physiological and sensorimotor impairment 
following mTBI (8, 11, 13, 14).  
The most frequent findings related to elevated levels of neck pain and disability, dizziness 
and hyperarousal (Table 2). Fifty percent of individuals post mTBI (76% symptomatic and 
21% asymptomatic) reported clinically relevant levels of neck pain and disability, and 45% 
(70% symptomatic and 17% asymptomatic) reported clinically relevant levels of dizziness 
associated handicap. These findings are consistent with that of Reneker et al (2018) (32) 
who observed evidence of cervical musculoskeletal impairment in 81.6% of mTBI cases, as 
well as studies associating neck pain and dysfunction with initial injury or long term outcome 
(47, 48). Findings also align with previous studies which identify dizziness as a commonly 
symptom post mTBI (49, 50). These findings now warrant further mechanistic research to 
identify the impairments associated with these symptoms that may include factors such as 
vestibular (peripheral or central) (51, 52), and or cervical musculoskeletal or sensorimotor 
impairments (53, 54).  
Clinically meaningful levels of hyperarrousal were also identified in 58% (19/33 individuals) 
of the symptomatic mTBI group. Hyperarrousal symptoms were also elevated among 
asymptomatic individuals (p<0.00), albeit clinically relevant in only one asymptomatic mTBI 
participant (Table 3). Elevated levels of hyperarousal symptoms may be relevant with regard 
to observed evidence of altered heart rate variability (HRV) and persistent ANS 
dysregulation post mTBI (8, 9, 44, 55). Reduced beat-to-beat variability thought to represent 
altered sympathovagal autonomic balance (56) has been identified in early and late stages 
(> 4 weeks) post-mTBI (8). While HRV changes have been observed in both symptomatic 
(9, 57) and asymptomatic individuals (8), no study has investigated the utility of symptom 
presentation in predicting ANS dysregulation post-mTBI.   
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Poorer reported sleep quality was also noted for all groups using the PSQI. Notably poorer 
sleep quality was observed in approximately twice the number of symptomatic (70%) 
compared to healthy control (32%) or asymptomatic (41%) participants. Multiple previous 
sleep studies (10, 58) including those using the PSQI (10, 59) have identified disturbed sleep 
patterns post mTBI. However, similar to findings in this current study, a high proportion of 
reported poor sleep quality has also been found among healthy individuals (59) indicating 
that impaired sleep quality may or may not be a useful indicator of recovery post-mTBI. 
Nevertheless, further investigation of the relationship between sleep and specific 
impairments post-mTBI is warranted given the impact of sleep quality on health and recovery 
following TBI (60).  
The findings suggest that for some individuals, standard self-report symptom scales such as 
the HIS may be inadequate to detect potentially relevant symptoms post-mTBI. In the 18 
asymptomatic participants in this study recording clinically relevant scores on impairment 
specific tools (NDI, hyperarousal, DHI, FSS, and DASS-21 depression), only 8 of these 
individuals attained clinically relevant scores using the HIS. Similar findings were also 
reported by Leddy et al (61) whose retrospective analysis demonstrated that no individual 
self-report symptom, or symptom cluster from a standard self-report symptom scale, could 
accurately subgroup individuals according to their physiologic, vestibular or cervical 
impairments. Hence, items in standard self-reported symptom scales (such as the HIS) may 
be too limited to identify those with potentially ongoing impairments. Given the elevated risk 
of injury recurrence (62, 63) and serious ramifications of repeated injury (64, 65), further 
prospective investigation as to appropriateness of these commonly used standard self-
reported symptom scales to infer recovery post mTBI is warranted.  This is particularly 
relevant given the absence of questions related to factors such as neck pain and disability in 
any of the widely used self-reported symptoms scales (21, 49, 66, 67) with the exception of 
the sport concussion assessment tools used for acute concussion assessment (68, 69).   
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From a clinical perspective the diverse nature of symptoms identified in this study 
demonstrates the need for differential examination and diagnosis post-mTBI (70). Results 
suggest multiple impairments may manifest post-mTBI. It is plausible that cervical spine or 
vestibular impairments, even in those reportedly symptom-free, may be present and should 
be routinely investigated post-injury with a view to secondary prevention (47). Additionally 
hyperarousal following mTBI can be a factor to consider given the well-documented 
relationship between these symptoms and HRV changes (71, 72).  
Limitations 
Scores derived from the impairment specific tools used in this study can only infer potential 
of underlying physical impairment; they are not diagnostic of impairment. Therefore, findings 
need to be taken in light of the need for further research to explore relationships between 
persisting symptoms and physical impairments. Additionally, since study inception a tool 
specifically for brain injury related vision symptoms has been developed (73). Thus, use of 
this tool may have identified differing results respecting presence of vision related 
symptoms, particularly among asymptomatic individuals. Furthermore, only the HIS was 
used in this study and therefore the utility of other self-reported symptoms scales remains 
unknown.  Potentially other self-reported symptom scales may demonstrate better capacity 
to stratify individuals into asymptomatic or symptomatic subgroups. Nevertheless, given the 
high prevalence of neck pain and disability in the current study and the absence of questions 
specifically related to the neck in standard self-reported symptom scales commonly used, it 
is not unreasonable to conclude that results may have been similar had a different scale 
been used.  
CONCLUSION 
A diverse range of symptoms potentially indicative of persisting impairments (eg. cervical, 
vestibular, physiological) may be present in individuals following mTBI beyond expected 
recovery time. Symptoms may also be present in individuals who overall consider 
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themselves symptom-free. Potentially generic self-reported symptom scales may not detect 
symptoms in these apparently asymptomatic individuals, questioning their appropriateness 
in determining recovery and ability to return to activity post-mTBI. Studies exploring the 
relationships between symptoms and system impairments in this patient group is urgently 
needed.  Findings suggest that decisions regarding recovery and return to activity following 
mTBI require differential examination that considers several factors including potential 
impairment of the cervical spine.  
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Figure 1. Impairment Specific Self-Reported Clinical Tools according to Cervical, Sensorimotor, Physiological and Psychological 
Domains 
 
Impairment 
Specific 
Screening 
Tools
Cervical Neck Disability Index 
(24)
Sensorimotor
Dizziness Handicap 
Inventory (36)
Visual Complaints 
Index (37)
Space and Motion 
Discomfort II (38)
Physiological
Fatigue Severity Scale 
(26)
Pittsburgh Sleep 
Quality index (27)
Hyperarrousal 
Subscale (40)
Psychological
Depression Anxiety 
Stress Scale 21 - Short 
Form (28)
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Highlights - At greater than four weeks post-injury; 
• 94% of symptomatic individuals post-mTBI scored above threshold on clinical 
tools. 
• 62% of asymptomatic individuals post-mTBI scored above threshold on 
clinical tools. 
• Only 28% of asymptomatic individuals were identified by a post-mTBI 
symptom scale. 
• A significant number of individuals post-mTBI may experience ongoing 
impairments.  
• Standard post-mTBI symptom tools may not detect all impairments post 
injury. 
 
